Home » Topics » BioWorld Science

BioWorld Science
RSS

Asahi Kasei Pharma initates phase III study of isavuconazole for deep-seated mycosis

April 18, 2018

FDA grants orphan drug designation to KL-1333 for inherited mitochondrial respiratory chain diseases

April 18, 2018

EPL-1410 demonstrates potential as immune-oncology therapeutic in preclinical models

April 18, 2018

Anavex to initiate phase II trial of ANAVEX2-73 in Parkinson's disease dementia

April 18, 2018

Third endometriosis program enters phase I under Evotec and Bayer alliance

April 18, 2018

Targeting NLRP3 shows promise for NASH and fibrosis

April 18, 2018

FDA approves Tavalisse for chronic ITP

April 18, 2018

DSMB recommends continuation of phase I/IIa study of VBI-1901 in recurrent GBM

April 18, 2018

Theralase updates results from phase Ib study of TLD-1433 in nonmuscle invasive bladder cancer

April 18, 2018

Exosomal miRNAs linked to radioresistant lung adenocarcinoma

April 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...